Early research (Phase 1)Study completedNCT00002153
What this trial is testing
Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders
Who this might be right for
Sarcoma, KaposiHIV InfectionsLymphoproliferative Disorders
DEKK-TEC, Inc. 25